OMER
$17.87
▼ −3.14%09/18 O 18.69 H 18.69 L 17.68 C 17.87 ▼ −3.14%
Vol 2.2M RS 98
Vol 2.2M RS 98
RS rating98
Now vs pivot (%)−9.06%
Tightening (ATR ratio)1.12×
Volume dry-up0.83×
Up/down volume, net0.28
From 52-week high9%
forming
Omeros Corporation
OMER · Pharmaceutical Preparations · $1.3B
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The four are not in order. That is a description of where the averages sit, not a view about what happens next.
The read
The base has run 3.6 weeks and fell 16% from its ceiling at its deepest. The pivot is $19.65, and the stock closed 9.1% below it. Its relative strength rating is 98.
Peers
Catalyst roadmap
- EarningstentativeLLY · competitorin 41dLLY reportsOct 29, 2026
- Earningstentativein 55dQuarterly earningsNov 12, 2026
Flagged by the market sweep
GappedTape · 2026-09-18
+6.4%
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
No headlines for this company in the last couple of weeks.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray